Michael Morabito
Stock Analyst at Chardan Capital
(0.17)
# 4,417
Out of 5,090 analysts
6
Total ratings
16.67%
Success rate
-13.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Morabito
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics | Maintains: Buy | $79 → $81 | $54.55 | +48.49% | 2 | Mar 17, 2021 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $202 → $203 | $577.30 | -64.84% | 2 | Feb 26, 2021 | |
| VKTX Viking Therapeutics | Maintains: Buy | $15 → $20 | $38.55 | -48.12% | 2 | Aug 31, 2020 |
Akero Therapeutics
Mar 17, 2021
Maintains: Buy
Price Target: $79 → $81
Current: $54.55
Upside: +48.49%
Madrigal Pharmaceuticals
Feb 26, 2021
Maintains: Buy
Price Target: $202 → $203
Current: $577.30
Upside: -64.84%
Viking Therapeutics
Aug 31, 2020
Maintains: Buy
Price Target: $15 → $20
Current: $38.55
Upside: -48.12%